Karyopharm Therapeutics Competitors, Revenue, Alternatives and Pricing

Claim your profile


Boston, MA USA
Total Funding:$178.3M
Lead Investor(s):BofA Merrill Lynch, J.P. Morgan Securities LLC

Estimated Revenue & Financials

  • Karyopharm Therapeutics's estimated annual revenue is currently $30.3M per year.(?)
  • Karyopharm Therapeutics received $Undisclosed in venture funding in January 2015.
  • Karyopharm Therapeutics's estimated revenue per employee is $67,115
  • Karyopharm Therapeutics's total funding is $178.3M.

Employee Data

  • Karyopharm Therapeutics has 452 Employees.(?)
  • Karyopharm Therapeutics grew their employee count by 50% last year.
  • Karyopharm Therapeutics currently has 1 job openings.

Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company focused on discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. For more information, please visit www.karyopharm.com

keywords:Biotechnology,Cleantech,Healthcare,Marketing,Pharmaceuticals,Wind Power